Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

 
NIH National Institute of Dental and Craniofacial Research (NIDCR) Home page
  • Health Info
  • Research
  • Grants & Funding
  • Careers & Training
  • News & Events
  • About Us
  • Health Info
    • Publications
    • Clinical Trials
    • Data & Statistics
    • Finding Dental Care
  • Research
    • Research Conducted at NIDCR (Intramural)
    • Research Funded by NIDCR (Extramural)
    • Human Subjects Research
    • Clinical Trials
    • Data & Statistics
    • Scientific Data Sharing
    • Research Priorities
    • Research Investments & Advances
    • Oral Health in America Report
    • COVID-19
  • Grants & Funding
    • Notices of Funding Opportunities
    • Grant Programs and Contacts
    • Funding Priorities
    • Funded Research
    • Human Subjects Research
    • Scientific Data Sharing
  • Careers & Training
    • Research Training at NIDCR (Intramural Opportunities)
    • Funding for Research Training (Extramural Opportunities)
    • Job Openings
    • Loan Repayment
    • Staff Contacts
  • News & Events
    • NIDCR News
    • Newsletter
    • Grantee News
    • Events
    • Images
    • For Reporters
  • About Us
    • Leadership & Staff
    • Advisory Committees
    • Strategic Plan
    • Oral Health in America Report
    • Congressional & Budget
    • Job Openings
    • Getting to NIDCR
    • Contact Us
    • Mission

Breadcrumb

  1. Home
  2. News & Events
  3. Newsletter
News & Events
  • NIDCR News
  • Newsletter
  • Grantee News
  • Events
  • Images
  • For Reporters

Fall 2021

In This Issue

  1. NIDCR News
  2. Science Advances
  3. NIH/HHS News
  4. Funding Opportunities & Notices
  5. Previous Issues
  6. Subscribe to NIDCR News

NIDCR News

5 Q&As About Oral Health in America: Advances and Challenges
Q&A stock image

NIDCR issued a brief Q&A regarding details of the forthcoming report Oral Health in America: Advances and Challenges, which will be published in Fall 2021. This comprehensive report will examine improvements in oral health over the past two decades, describe challenges and opportunities that affect oral health, and articulate a vision for the future, calling upon all Americans to take action. The report will provide key insights into the importance of oral health research and its impact on public health, including the importance of equitable delivery of oral health care.

NIDCR at IADR/AADOCR/CADR General Session
Dr. Lois Cohen

NIDCR leadership, program staff, investigators, and trainees were among the presenters and honorees at the 2021 virtual meeting of the International Association for Dental Research (IADR); American Association for Dental, Oral, and Craniofacial Research (AADOCR); and Canadian Association for Dental Research:

  • In a virtual interactive session with more than 100 participants, NIDCR Director Rena D’Souza, DDS, MS, PhD, provided an overview of NIDCR’s current programs and activities. She described her vision for achieving the institute’s mission to advance fundamental knowledge about dental, oral, and craniofacial health and disease and translate these findings into prevention, early detection, and treatment strategies that improve overall health for all individuals and communities across the lifespan. Recordings of this session and other NIDCR-related events can be viewed by registered meeting attendees on the IADR virtual platform.
  • Lois Cohen, PhD, received the 2021 IADR Distinguished Scientist Award in Global Oral Health Research for her contributions to the field of social and behavioral research in dentistry.
  • Rei Sekiguchi, DDS, PhD, and Ken Yamada, PhD, received The Journal of Dental Research Cover of the Year Award in recognition of their paper, "Single-Cell RNA-seq Identifies Cell Diversity in Embryonic Salivary Glands."
  • Former NIDCR director and current investigator at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Martha Somerman, DDS, PhD, received the AADR Jack Hein Public Service Award, which honors service in promoting oral health research interests and activities to the public.
  • Clinical research fellow Joshua Emrick, DDS, PhD, won first place among more than 20 contestants in the AADR Hatton Competition for his presentation at the meeting.
  • Predoctoral fellow Jeremie Oliver, MS, received the Craniofacial Biology Group Award (Junior Category) for his presentation; Oliver works in the lab of Dr. D’Souza.
Upcoming Workshop: Immune Systems Role in Tissue Regeneration
NASEM VIrtual Workshop

The National Academies of Sciences, Engineering, and Medicine (NASEM) will host a two-day virtual workshop titled “Understanding the Role of the Immune System in Improving Tissue Regeneration” on November 2-3, 2021. Co-organized by NIDCR, the free workshop will explore promising approaches to improve clinical outcomes of tissue repair and regeneration in patients. This workshop is part of NASEM’s Forum on Regenerative Medicine. Register here.

Back to top

Science Advances

Portable Coronavirus Sensor Gives Results in Seconds
COVID-19 Sensor

In a preliminary study funded by NIDCR, researchers developed a hand-held device that rapidly and reliably detects SARS-CoV-2 in artificial saliva. The portable sensor could eventually be used for low-cost COVID-19 testing in a variety of locations, including dental and health care settings, schools, the travel industry, and at home.

Dialing Down Pain from the Brain
In mice, corticospinal neurons mainly govern voluntary movements. But Liu discovered that a subset of the neurons (above) amplifies touch signals and plays a role in mechanical allodynia, where gentle touch is perceived as pain.

NIDCR Stadtman investigator Yuanyuan “Kevin” Liu, PhD, is decoding brain-spinal cord conversation to understand how the brain perceives touch and pain. His research revealed a brain area in mice that acts as a volume control for mechanical allodynia, a neuropathic pain condition where light touch is perceived as painful. The findings could have broader implications for other pain disorders and reveal potential treatment targets.

Mimicking Mother Nature to Grow an Artificial Gland
Artificial Buds

A video on NIDCR’s website shows a salivary gland growing into a mature organ and features NIDCR scientists as they describe how they achieved the first key step in creating an artificial salivary gland. The researchers are exploring ways to restore or replace damaged salivary glands to help patients who have lost salivary function from certain conditions, such as Sjögren's disease or radiation therapy for head and neck cancer.

Cracking Down on a Rare Bone Disorder
Pediatric endocrinologist Alison Boyce, MD

Pediatric endocrinologist Alison Boyce, MD, is looking for better ways to treat and diagnose fibrous dysplasia/McCune Albright Syndrome (FD/MAS), a disorder of the bones, skin, and endocrine system. In a video, she emphasizes the importance of engaging the FD/MAS patient community to understand their hopes and needs, which can inform research efforts to tackle the condition.

How to Heal Skin Without the Scars
New treatment to prevent scarring

Scientists supported by NIDCR and the National Institute of General Medical Sciences discovered how to reprogram certain mouse skin cells with a topical treatment to make them respond to injuries more like fetal skin cells, which patch up wounds without leaving a mark. The findings suggest it may one day be possible to allow wounds to heal without compromising the integrity of the skin. The findings also may have implications for other medical afflictions that involve scarring, such as liver and lung fibrosis, burns, scleroderma, and scarring of heart tissue after a heart attack.

Back to top

NIH/HHS News

Lander, Collins Set Forth Vision for ARPA-H
Lander, Collins Set Forth Vision for ARPA-H

In a commentary published in Science, White House Office of Science and Technology Policy Director Eric S. Lander, PhD, NIH Director Francis S. Collins, MD, PhD, and other leaders describe a vision for a new science entity, the Advanced Research Projects Agency for Health (ARPA-H). Proposed as a distinct division within NIH, ARPA-H would embrace a culture and strategies that encourage bold advances, aiming to accelerate biomedical innovation and adopt technologies and approaches to revolutionize health care and medicine. In one of a series of listening sessions convened by NIH and OSTP, NIH leadership, including NIDCR Director Dr. D'Souza, gave presentations and gathered feedback from stakeholders in several disease-related areas, including dental and craniofacial disorders.

Oral & Pharynx Cancer Death Rates Increase in Men
Oral & Pharynx Cancer Death Rates Increase in Men

The Annual Report to the Nation on the Status of Cancer, released in July by the National Cancer Institute and collaborating organizations, found that overall cancer death rates have continued to decline in men and women for all racial and ethnic groups in the United States. However, oral cavity and pharynx cancer death rates increased for men from 2014 to 2018. The overall cancer incidence rates continue to increase among females, children, and adolescents and young adults.

Adolescent Nicotine Vaping Declined During Pandemic
Student working at a desk

Nicotine vaping in American high school seniors declined during the COVID-19 pandemic, according to results from the annual Monitoring the Future survey of substance use behaviors among US adolescents. The study, funded by the National Institute on Drug Abuse, suggested that a dip in the perceived supply of vaping devices, the rise of minimum age for vaping product purchases, and news reports on vaping-induced lung injuries may have contributed to the decline. Meanwhile, adolescent marijuana use and binge drinking did not significantly change during the same period.

Deputy Director for NIH Intramural Research Steps Down
Michael M. Gottesman, MD

After 28 years of service, Michael M. Gottesman, MD, will step down as the NIH deputy director of intramural research and will turn his focus to his work at NCI, where he is chief of the Laboratory of Cell Biology. During his leadership, Gottesman has coordinated activities and facilitated cooperation to improve research integrity, recruitment, and foster a diverse scientific workforce across NIH. Gottesman will remain in the position while NIH undertakes a nationwide search for his replacement.

Back to top
Funding Opportunities & Related Notices
Title Opportunity number Extramural Scientific Topics Release Date Expiration Date
Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)
RFA-DE-22-005
  • Craniofacial Skeletal Biology & Pathobiology
  • Gene Discovery, Genomics & Multi-Omics Analysis
08/12/2021
11/11/2021
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
RFA-RM-21-025
  • Career Development
  • Research Training & Fellowships
07/12/2021
09/25/2021
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)
PAR-21-280
  • Behavioral & Social Science
07/09/2021
05/08/2023
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)
PAR-21-281
  • Behavioral & Social Science
07/09/2021
05/08/2023
PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
PA-21-259
  • Parent Announcements & Trans-NIH Announcements
  • Small Business (SBIR/STTR)
01/31/2022
04/06/2022
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
PA-21-262
  • Parent Announcements & Trans-NIH Announcements
  • Small Business (SBIR/STTR)
07/08/2021
04/06/2022
Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
PAR-21-253
  • Oral Microbiota and Bacterial Disease
07/06/2021
10/20/2023
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
PA-21-268
  • Behavioral & Social Science
  • Bioinformatics, Computational Biology & Data Science
  • Career Development
  • Clinical Research & Clinical Trials
  • Common Fund Programs
  • Conferences & Meetings
  • COVID-19
  • Craniofacial & Dental Developmental Biology
  • Craniofacial Skeletal Biology & Pathobiology
  • Dental Caries
  • Dental Materials & Biomaterials
  • Dissemination & Implementation Science
  • Epidemiology
  • Fluoride & Fluorosis
  • Gene Discovery, Genomics & Multi-Omics Analysis
  • Global Health
  • HIV/AIDS & Oral Health
  • International Research Activities
  • Mineralized Tissues & Mineralization
  • Mucosal Diseases
  • National Dental Practice-Based Research Network
  • Oral & Comprehensive Health
  • Oral Health Disparities Research
  • Oral Immunology, Immunopathology & Immunotherapy
  • Oral Microbiology & Metagenomics
  • Oral Microbiota and Bacterial Disease
  • Oral Opportunistic Pathogens and Viral Disease
  • Oral, Oropharyngeal & Salivary Gland Cancers
  • Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology
  • Parent Announcements & Trans-NIH Announcements
  • Periodontal Diseases
  • Research Training & Fellowships
  • Salivary Biology & Dysfunction
  • Small Business (SBIR/STTR)
  • Statistical Analysis & Data Science
  • Technology Development
  • Tissue Engineering & Regenerative Medicine
06/30/2021
07/01/2024
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
RFA-DE-22-003
  • HIV/AIDS & Oral Health
  • Oral, Oropharyngeal & Salivary Gland Cancers
06/29/2021
11/19/2021
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)
RFA-DE-22-004
  • HIV/AIDS & Oral Health
  • Oral, Oropharyngeal & Salivary Gland Cancers
06/28/2021
11/19/2021
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
RFA-NS-21-029
  • Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology
06/08/2021
10/11/2023
Notice of Expiration of PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required).
NOT-DE-21-011
  • Behavioral & Social Science
07/29/2021
01/01/2027
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management
NOT-AT-21-012
  • Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology
  • Technology Development
07/20/2021
01/01/2027
Notice of Correction to Application Types Allowed for PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
NOT-DE-21-009
  • Behavioral & Social Science
  • Oral Health Disparities Research
07/02/2021
01/01/2028
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
NOT-OD-21-092
  • Behavioral & Social Science
  • Technology Development
06/28/2021
11/17/2023
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects
NOT-OD-21-127
  • Mucosal Diseases
  • Oral Immunology, Immunopathology & Immunotherapy
  • Oral Microbiology & Metagenomics
  • Oral, Oropharyngeal & Salivary Gland Cancers
06/28/2021
05/08/2023
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
NOT-OD-21-137
  • Epidemiology
  • Mucosal Diseases
  • Oral, Oropharyngeal & Salivary Gland Cancers
06/28/2021
05/08/2024
Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease
NOT-AG-21-018
  • Parent Announcements & Trans-NIH Announcements
06/25/2021
10/02/2021
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition
NOT-HD-21-027
  • Behavioral & Social Science
  • Clinical Research & Clinical Trials
  • Dissemination & Implementation Science
06/22/2021
01/08/2024
Notice of NIDCR Participation in RFA-CA-21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
NOT-DE-21-005
  • Oral, Oropharyngeal & Salivary Gland Cancers
06/23/2021
01/01/2027
Notice of NIDCR Participation in PAR-21-168, "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
NOT-DE-21-006
  • Career Development
  • Research Training & Fellowships
06/22/2021
01/01/2028
Back to top

Previous Issues

2025
Spring 2025
2024
Winter 2024
Fall 2024
Summer 2024
Spring 2024
2023
Winter 2023
Fall 2023
Summer 2023
2022
Winter 2022
Fall 2022
Summer 2022
Last Reviewed
August 2021
NIH
  • Home
  • Web Policies
  • Privacy
  • Contact Us
  • Freedom of Information Act
  • No Fear Act
  • Office of Inspector General
  • HHS Vulnerability Disclosure
  • Employee Intranet - Staff Only
Back to top